GO:0042700 luteinizing hormone signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042700 (luteinizing hormone signaling pathway) is a G protein-coupled receptor signaling pathway initiated by luteinizing hormone binding to its receptor on the surface of a target cell, ending with regulation of a downstream cellular process.
• The pathway is best known for triggering the mid-cycle LH surge that drives oocyte meiotic resumption, ovulation, and corpus luteum formation in the ovary.
• Beyond reproduction, LH signaling restricts hematopoietic stem cell expansion during puberty, showing the pathway operates in non-gonadal tissues.
• LH signaling is tightly regulated by hypothalamic-pituitary inputs and local ovarian factors such as retinoic acid, semaphorin 3E-Plexin-D1, and Slit ligands.
• Disruption of LH signaling causes gonadotrophin resistance and reproductive disorders, and altered LH action is linked to oocyte quality and age-related brain changes.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect causal roles of LH pathway genes in vivo and in vitro.
Description
The luteinizing hormone signaling pathway (GO:0042700) is a biological process in which luteinizing hormone (LH) binds to its G protein-coupled receptor (LHCGR) on the surface of a target cell and initiates a signaling cascade that ultimately regulates downstream cellular processes. This pathway is essential for normal reproductive physiology, most notably for triggering the mid-cycle LH surge that induces oocyte meiotic resumption, ovulation, and luteinization of granulosa cells in the ovary. Because LH signaling coordinates endocrine and paracrine signals across the hypothalamic-pituitary-gonadal axis, it has become a central focus for researchers studying fertility, oocyte quality, and reproductive aging. In addition to its canonical gonadal roles, LH signaling has been shown to influence non-reproductive tissues. For example, LH signaling restricts hematopoietic stem cell expansion during puberty, revealing a broader physiological reach for this pathway. The pathway is also subject to complex regulation by local factors such as retinoic acid, semaphorin 3E-Plexin-D1, and Slit ligands, which fine-tune LH-induced responses in granulosa cells. Understanding these mechanisms is critical for developing therapeutic strategies for gonadotrophin resistance, infertility, and other LH-related disorders. For researchers, GO:0042700 provides a structured framework to study how a single hormone-receptor interaction can orchestrate diverse cellular outcomes, from meiotic resumption to stem cell quiescence. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to outline the definition, mechanisms, key genes, disease links, and experimental models relevant to the luteinizing hormone signaling pathway.
luteinizing hormone signaling pathway At A Glance
| GO ID | GO:0042700 |
|---|---|
| GO term | luteinizing hormone signaling pathway |
| Ontology | biological_process |
| Synonym | luteinizing hormone signalling pathway |
| Definition | A G protein-coupled receptor signaling pathway initiated by luteinizing hormone binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. |
| Major function | Transduces the LH signal from the cell surface to intracellular effectors, controlling oocyte maturation, ovulation, luteinization, and other downstream cellular responses. |
| Receptor | LHCGR (luteinizing hormone/choriogonadotropin receptor), a G protein-coupled receptor. |
| Key tissues | Ovarian granulosa and theca cells, testicular Leydig cells, and hematopoietic stem cells. |
| Physiological trigger | The mid-cycle LH surge from the anterior pituitary. |
What Is GO:0042700?
According to the Gene Ontology, GO:0042700 (luteinizing hormone signaling pathway) is defined as a G protein-coupled receptor signaling pathway initiated by luteinizing hormone binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. In simpler terms, it is the entire sequence of molecular events that begins when LH docks onto its receptor and concludes with changes in how the target cell behaves, such as altered gene expression, cell cycle progression, or differentiation.
Why Is luteinizing hormone signaling pathway Important in Cell Biology?
The luteinizing hormone signaling pathway is indispensable for mammalian reproduction and has broader roles in stem cell regulation and neuroendocrine function. Defects in this pathway cause gonadotrophin resistance, infertility, and abnormal pubertal development, while dysregulated LH action is implicated in age-related brain changes and oocyte quality decline. Because the pathway is a G protein-coupled receptor cascade, it serves as a paradigm for understanding how hormonal signals are converted into diverse cellular outcomes, making it a high-value target for both basic and translational research.
• Triggers oocyte meiotic resumption and ovulation, making it essential for female fertility.
• Drives luteinization of granulosa cells and corpus luteum formation, supporting progesterone production.
• Regulates hematopoietic stem cell expansion during puberty, linking reproduction to stem cell biology.
• Its dysfunction causes gonadotrophin resistance and reproductive disorders in humans.
• Altered LH signaling is associated with age-related changes in the brain.
• Local factors such as retinoic acid and semaphorin 3E-Plexin-D1 modulate LH-induced ovulation and angiogenesis.
• Slit1 and Slit2 have redundant functions in ovarian granulosa cells, fine-tuning LH responses.
• Urocortin 2-CRHR2 signaling can suppress LH secretion, revealing neuroendocrine control of the pathway.
• The pathway is a model for GPCR-mediated signal transduction and drug targeting.
• CRISPR-based models enable causal dissection of LH pathway genes in vivo.
What Happens During luteinizing hormone signaling pathway?
LH binding to LHCGR and G protein activation
In simple terms: LH acts like a key that fits the LHCGR lock on the cell surface, turning on G proteins inside the cell.
The pathway begins when luteinizing hormone binds to its G protein-coupled receptor, LHCGR, on the surface of target cells such as ovarian granulosa cells. This binding induces a conformational change in the receptor that activates heterotrimeric G proteins, leading to the production of second messengers like cAMP and activation of downstream kinases. This initial step is the defining event of GO:0042700 and is required for all subsequent cellular responses.
Activation of downstream effectors and second messenger cascades
In simple terms: The signal is amplified inside the cell through a relay of molecules that carry the message forward.
Following G protein activation, the LH signal is transduced through multiple intracellular cascades, including the cAMP/PKA pathway, which phosphorylates target proteins and alters gene expression. These signaling events converge on the regulation of downstream cellular processes such as meiotic resumption in oocytes and luteinization in granulosa cells. The pathway also intersects with retinoic acid signaling, which is important for LH-induced oocyte meiotic resumption.
Oocyte meiotic resumption and ovulation
In simple terms: The LH surge tells the egg to mature and the follicle to release it.
A key physiological outcome of LH signaling is the resumption of meiosis in the oocyte and subsequent ovulation. The mid-cycle LH surge triggers these events by activating signaling cascades in granulosa cells that communicate with the oocyte. Semaphorin 3E-Plexin-D1 signaling downstream of the LH surge regulates ovulation, granulosa cell luteinization, and ovarian angiogenesis in mice. This step is critical for fertility and is a major focus of reproductive research.
Luteinization and corpus luteum formation
In simple terms: After ovulation, the remaining follicle cells transform into a gland that produces hormones.
Following ovulation, LH signaling promotes the luteinization of granulosa cells, leading to the formation of the corpus luteum, which produces progesterone to support early pregnancy. This process involves changes in gene expression and cell morphology driven by LH-activated pathways. The semaphorin 3E-Plexin-D1 pathway has been shown to regulate granulosa cell luteinization and ovarian angiogenesis downstream of the LH surge.
Non-gonadal roles: hematopoietic stem cell regulation
In simple terms: LH signaling also acts outside the reproductive system, for example by limiting stem cell expansion during puberty.
Beyond the gonads, LH signaling restricts hematopoietic stem cell expansion during puberty, demonstrating that the pathway operates in non-reproductive tissues. This finding expands the physiological relevance of GO:0042700 and suggests that LH may coordinate systemic developmental transitions. Researchers studying stem cell biology should consider LH signaling as a potential regulatory input.
Key Genes Involved in GO:0042700 luteinizing hormone signaling pathway
The following genes and proteins are central to the luteinizing hormone signaling pathway, based on verified literature and GO annotation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LHCGR | Luteinizing hormone/choriogonadotropin receptor; binds LH to initiate the pathway | Mutations cause gonadotrophin resistance; target for fertility studies |
| LHB | Luteinizing hormone beta subunit; forms the hormone that activates LHCGR | Essential for LH surge; knockout models show reproductive defects |
| CGA | Glycoprotein hormones alpha subunit; shared by LH and other glycoprotein hormones | Required for LH assembly and secretion |
| GNRHR | Gonadotropin-releasing hormone receptor; upstream regulator of LH secretion | Links hypothalamic control to LH signaling |
| PKA (PRKACA) | Protein kinase A; major downstream effector of LH signaling | Mediates phosphorylation cascades in granulosa cells |
| CREB1 | cAMP response element-binding protein; transcription factor activated by LH signaling | Regulates gene expression downstream of LH |
| AREG | Amphiregulin; EGF-like factor induced by LH in granulosa cells | Mediates LH-induced oocyte maturation |
| EREG | Epiregulin; EGF-like factor induced by LH | Participates in ovulation and cumulus expansion |
| PTGS2 | Prostaglandin-endoperoxide synthase 2; induced by LH surge | Critical for ovulation and inflammation-like processes |
| SEMA3E | Semaphorin 3E; regulates ovulation and angiogenesis downstream of LH | Knockout studies reveal roles in luteinization |
| PLXND1 | Plexin-D1; receptor for SEMA3E | Mediates semaphorin signaling in ovarian cells |
| SLIT1 | Slit guidance ligand 1; has redundant functions in granulosa cells | Modulates LH responses in the ovary |
| SLIT2 | Slit guidance ligand 2; redundant with SLIT1 in granulosa cells | Potential regulator of LH signaling |
| UCN2 | Urocortin 2; suppresses LH secretion via CRHR2 | Neuroendocrine regulator of LH |
| CRHR2 | Corticotropin-releasing hormone receptor 2; mediates UCN2 effects on LH | Involved in suppression of LH secretion |
| ALDH1A1 | Retinaldehyde dehydrogenase 1; involved in retinoic acid synthesis | Retinoic acid signaling is important for LH-induced meiotic resumption |
How Is luteinizing hormone signaling pathway Regulated?
The luteinizing hormone signaling pathway is regulated at multiple levels. Upstream, hypothalamic GnRH controls LH secretion from the pituitary, and Urocortin 2-CRHR2 signaling can suppress LH secretion in female mice. Locally in the ovary, retinoic acid signaling is important for LH-induced oocyte meiotic resumption, and Slit1/Slit2 have redundant functions in granulosa cells that modulate LH responses. The semaphorin 3E-Plexin-D1 pathway acts downstream of the LH surge to regulate ovulation, luteinization, and angiogenesis. These regulatory inputs ensure that LH signaling is precisely timed and tissue-specific.
luteinizing hormone signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LHCGR | Gonadotrophin resistance, infertility | Knockout mouse, patient-derived point mutations |
| LHB | Hypogonadism, delayed puberty | Knockout mouse, overexpression models |
| SEMA3E | Ovulation defects, angiogenesis disorders | Knockout mouse, granulosa cell culture |
| SLIT1/SLIT2 | Ovarian dysfunction | Double knockout mouse, RNAi knockdown |
| UCN2/CRHR2 | Suppressed LH secretion, stress-related reproductive dysfunction | Knockout mouse, pharmacological models |
Gonadotrophin resistance and reproductive disorders
Mutations in LHCGR or other components of the LH signaling pathway can cause gonadotrophin resistance, leading to infertility, delayed puberty, and abnormal sexual development. Understanding these defects helps clinicians diagnose and manage reproductive disorders. Research using patient-derived mutations and animal models has clarified how specific residues in LHCGR affect receptor function.
Oocyte quality and reproductive aging
Altered LH signaling is associated with reduced oocyte quality and age-related decline in fertility. Clinical studies have explored how LH action influences oocyte maturation and quality, with implications for assisted reproductive technologies. The pathway is a target for interventions aimed at improving IVF outcomes.
LH signaling in the aging brain
Luteinizing hormone and its signaling have been implicated in age-related changes in the brain, suggesting roles beyond reproduction. This opens new avenues for studying neurodegenerative processes and cognitive aging. Researchers are investigating whether modulating LH signaling could affect brain health.
Hematopoietic stem cell expansion and pubertal regulation
LH signaling restricts hematopoietic stem cell expansion during puberty, linking reproductive hormones to stem cell homeostasis. Dysregulation of this pathway could contribute to hematological abnormalities. This non-canonical role highlights the need for broader investigation of LH signaling in development.
From luteinizing hormone signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does LHCGR mediate LH-induced oocyte maturation? | Lhcgr knockout mouse or CRISPR knockout in granulosa cells |
| What is the role of a specific LHCGR point mutation in gonadotrophin resistance? | Point-mutation knock-in mouse or cell line |
| How does SEMA3E-Plexin-D1 signaling affect ovulation? | Sema3e or Plxnd1 knockout mouse |
| Does overexpression of SLIT1 rescue SLIT2 deficiency in granulosa cells? | Overexpression and double knockout models |
| Can tagged LHCGR reveal receptor trafficking? | Tagged knock-in of LHCGR |
| What is the effect of UCN2 on LH secretion? | Ucn2 knockout or CRHR2 antagonist in mice |
How to Study the luteinizing hormone signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify LH-induced transcriptional programs |
| Phosphoproteomics | Phosphorylation events | Map kinase cascades downstream of LHCGR |
| Live-cell imaging | cAMP, calcium, receptor trafficking | Visualize real-time signaling dynamics |
| CRISPR knockout | Loss-of-function effects | Test causal role of candidate genes |
| CRISPR knock-in | Tagged or mutant protein expression | Study receptor trafficking or point mutations |
| Overexpression | Gain-of-function effects | Assess sufficiency of a gene in the pathway |
| ChIP-seq | Transcription factor binding | Identify CREB targets downstream of LH |
| Proteomics | Protein abundance and interactions | Discover novel pathway components |
Transcriptomics and RNA-seq
RNA sequencing can identify global changes in gene expression following LH stimulation in granulosa cells or other target tissues. This method helps uncover downstream effectors of GO:0042700 and regulatory networks. Comparative transcriptomics between wild-type and knockout models reveals pathway-specific signatures.
Phosphoproteomics and signaling profiling
Phosphoproteomics measures phosphorylation events downstream of LHCGR activation, providing a snapshot of kinase activity. This approach can identify novel components of the LH signaling cascade. It is particularly useful for studying rapid post-translational modifications.
Imaging and live-cell assays
Live-cell imaging with fluorescent reporters can track cAMP levels, calcium flux, and receptor internalization in response to LH. These techniques allow real-time visualization of signaling dynamics in target cells. They are valuable for validating findings from genetic models.
CRISPR-based functional genomics
CRISPR knockout and knock-in models enable causal testing of candidate genes in the LH pathway. Pooled CRISPR screens can identify modifiers of LH signaling in high throughput. These methods are essential for moving from correlation to causation.
How CRISPR Can Be Used to Study GO:0042700 luteinizing hormone signaling pathway
Knockout
CRISPR knockout of LHCGR or downstream effectors can abolish LH signaling, providing definitive evidence of their requirement in processes like oocyte maturation and ovulation. Knockout mouse models have been instrumental in linking specific genes to gonadotrophin resistance and fertility defects. In vitro knockout in granulosa cell lines allows rapid functional testing.
Point Mutation
Point mutations in LHCGR identified in patients with gonadotrophin resistance can be introduced into cell lines or mice using CRISPR to study structure-function relationships. This approach reveals how single amino acid changes affect receptor activation, trafficking, or ligand binding. It is also useful for dissecting signaling bias.
Knock-in
Knock-in of tagged LHCGR or reporter genes enables visualization of receptor localization and dynamics in vivo. Knock-in of human disease mutations into mouse models provides a platform for testing therapeutic interventions. This strategy preserves endogenous regulatory elements for physiological relevance.
Overexpression
Overexpression of LH pathway components, such as SLIT1 or SEMA3E, can test sufficiency in driving downstream responses like luteinization or angiogenesis. Overexpression models are particularly useful when knockout phenotypes are subtle due to redundancy. They can also be combined with knockout backgrounds to assess rescue.
How EDITGENE Supports luteinizing hormone signaling pathway Research
Researchers studying luteinizing hormone signaling pathway-related genes often need to determine whether a candidate gene is causally involved in LH-induced cellular responses. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional dissection of GO:0042700.
Contact EDITGENE today to design your custom CRISPR model for luteinizing hormone signaling pathway research.
Frequently Asked Questions About luteinizing hormone signaling pathway
What is the luteinizing hormone signaling pathway?
The luteinizing hormone signaling pathway (GO:0042700) is a G protein-coupled receptor signaling pathway initiated by luteinizing hormone binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process.
What genes are involved in luteinizing hormone signaling pathway?
Key genes include LHCGR, LHB, CGA, PKA (PRKACA), CREB1, AREG, EREG, PTGS2, SEMA3E, PLXND1, SLIT1, SLIT2, UCN2, and CRHR2.
What is the GO ID for luteinizing hormone signaling pathway?
The GO ID is GO:0042700, under the biological_process ontology.
How does LH signaling trigger ovulation?
The mid-cycle LH surge activates LHCGR on granulosa cells, inducing downstream signaling cascades that lead to oocyte meiotic resumption, follicle rupture, and luteinization.
What diseases are associated with defective LH signaling?
Defective LH signaling can cause gonadotrophin resistance, infertility, delayed puberty, and has been linked to age-related brain changes.
Does LH signaling occur outside the reproductive system?
Yes, LH signaling restricts hematopoietic stem cell expansion during puberty, showing non-gonadal roles.
What is the role of retinoic acid in LH signaling?
Intrafollicular retinoic acid signaling is important for LH-induced oocyte meiotic resumption.
How is LH secretion regulated?
LH secretion is controlled by hypothalamic GnRH and can be suppressed by Urocortin 2-CRHR2 signaling in female mice.
What experimental models are used to study LH signaling?
Common models include Lhcgr knockout mice, point-mutation knock-in mice, granulosa cell lines, and CRISPR knockout cell models.
How can CRISPR help study the LH signaling pathway?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in the pathway, while CRISPR screens identify novel regulators.
Conclusion
The luteinizing hormone signaling pathway (GO:0042700) is a fundamental biological process that translates the LH signal into diverse cellular outcomes, from oocyte maturation and ovulation to stem cell regulation. Its dysregulation is linked to reproductive disorders, age-related brain changes, and other pathologies, making it a critical area of research. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of new pathway components and therapeutic targets. EDITGENE offers a comprehensive suite of CRISPR services to support functional studies of LH signaling genes, empowering researchers to uncover causal mechanisms and develop novel interventions.
References
- 1. Arroyo A et al.. 2020. Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact.. Reprod Sci 27(6):1223-1252 PMID: 32046451
- 2. Mey M et al.. 2021. Luteinizing hormone and the aging brain.. Vitam Horm 115:89-104 PMID: 33706966
- 3. Wang F et al.. 2023. Intrafollicular Retinoic Acid Signaling Is Important for Luteinizing Hormone-Induced Oocyte Meiotic Resumption.. Genes (Basel) 14(4) PMID: 37107703
- 4. Grudet F et al.. 2025. Redundant functions and mechanisms of action of Slit1 and Slit2 in ovarian granulosa cells.. Reproduction 170(5) PMID: 40996529
- 5. Peng YJ et al.. 2018. Luteinizing hormone signaling restricts hematopoietic stem cell expansion during puberty.. EMBO J 37(17) PMID: 30037826
- 6. Huhtaniemi I et al.. 2006. Gonadotrophin resistance.. Best Pract Res Clin Endocrinol Metab 20(4):561-76 PMID: 17161332
- 7. McCosh RB et al.. 2025. Suppression of Luteinizing Hormone Secretion in Female Mice by a Urocortin 2-CRHR2 Signaling Pathway.. Endocrinology 166(5) PMID: 40037626
- 8. Zhang H et al.. 2025. Semaphorin 3E-Plexin-D1 Pathway Downstream of the Luteinizing Hormone Surge Regulates Ovulation, Granulosa Cell Luteinization, and Ovarian Angiogenesis in Mice.. Adv Sci (Weinh) 12(29):e17163 PMID: 40391781
